Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02604277 · ClinicalTrials.gov registry record · NA

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

A NA study of Depression and Alcoholism, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT02604277 is a NA study of Depression and Alcoholism that is actively recruiting participants, run by Emory University. The registered enrollment target is 130 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02604277, a NA study of Depression and Alcoholism, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program.

Interventions

  • BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
  • BEHAVIORAL Interpersonal and Social Rhythm Therapy (ISRT)
  • BEHAVIORAL Bipolar-Specific Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Psycho-education & Understanding Bipolar Medications Therapy

Study Locations (1)

Georgia

  • Grady Health System - Atlanta

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2016-01
Est. Completion 2026-12
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02604277

The ClinicalTrials.gov registry entry for NCT02604277 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.

NCT02604277 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02604277 about?

NCT02604277 is a clinical study titled "Suicidal Behavior in Patients Diagnosed With Bipolar Disorder". The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based interven...

What is the current status of trial NCT02604277?

This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2016-01. Estimated completion is 2026-12.

What conditions does trial NCT02604277 study?

This clinical trial studies the following conditions: Depression, Alcoholism, Drug Abuse.

What interventions are being tested in trial NCT02604277?

The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL), Interpersonal and Social Rhythm Therapy (ISRT) (BEHAVIORAL), Bipolar-Specific Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Psycho-education & Understanding Bipolar Medications Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02604277?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02604277 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.